125 related articles for article (PubMed ID: 35641401)
1. Commentary on Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
Fischer CE
Am J Geriatr Psychiatry; 2022 Nov; 30(11):1209-1211. PubMed ID: 35641401
[No Abstract] [Full Text] [Related]
2. Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
Sano M; Zhu CW; Neugroschl J; Grossman HT; Schimming C; Aloysi A
Am J Geriatr Psychiatry; 2022 Nov; 30(11):1198-1208. PubMed ID: 35562259
[TBL] [Abstract][Full Text] [Related]
3. Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition.
Sano M; Cummings J; Auer S; Bergh S; Fischer CE; Gerritsen D; Grossberg G; Ismail Z; Lanctôt K; Lapid MI; Mintzer J; Palm R; Rosenberg PB; Splaine M; Zhong K; Zhu CW
Int Psychogeriatr; 2024 Apr; 36(4):238-250. PubMed ID: 36880250
[TBL] [Abstract][Full Text] [Related]
4. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set.
Beekly DL; Ramos EM; Lee WW; Deitrich WD; Jacka ME; Wu J; Hubbard JL; Koepsell TD; Morris JC; Kukull WA;
Alzheimer Dis Assoc Disord; 2007; 21(3):249-58. PubMed ID: 17804958
[TBL] [Abstract][Full Text] [Related]
5. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
[TBL] [Abstract][Full Text] [Related]
7. Network analysis of neuropsychiatric symptoms in Alzheimer's disease.
Goodwin GJ; Moeller S; Nguyen A; Cummings JL; John SE
Alzheimers Res Ther; 2023 Aug; 15(1):135. PubMed ID: 37568209
[TBL] [Abstract][Full Text] [Related]
8. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.
Besser L; Kukull W; Knopman DS; Chui H; Galasko D; Weintraub S; Jicha G; Carlsson C; Burns J; Quinn J; Sweet RA; Rascovsky K; Teylan M; Beekly D; Thomas G; Bollenbeck M; Monsell S; Mock C; Zhou XH; Thomas N; Robichaud E; Dean M; Hubbard J; Jacka M; Schwabe-Fry K; Wu J; Phelps C; Morris JC;
Alzheimer Dis Assoc Disord; 2018; 32(4):351-358. PubMed ID: 30376508
[TBL] [Abstract][Full Text] [Related]
9. Psychiatrists and Alzheimer's disease.
Cazas A; Flame E; Ginestet D
Biomed Pharmacother; 1989; 43(7):501-4. PubMed ID: 2819237
[TBL] [Abstract][Full Text] [Related]
10. [The nurse, recurrent cries].
Maeker É; Franchet M; Maeker-Poquet B
Soins Gerontol; 2023; 28(164):24-26. PubMed ID: 37977761
[TBL] [Abstract][Full Text] [Related]
11. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
Morris JC
Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
[TBL] [Abstract][Full Text] [Related]
12. Depressive, functional status, and neuropsychiatric symptom trajectories before an Alzheimer's disease diagnosis.
Gaugler JE; Hovater M; Roth DL; Johnston JA; Kane RL; Sarsour K
Aging Ment Health; 2014; 18(1):110-6. PubMed ID: 23822174
[TBL] [Abstract][Full Text] [Related]
13. Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.
Kirson NY; Scott Andrews J; Desai U; King SB; Schonfeld S; Birnbaum HG; Ball DE; Kahle-Wrobleski K
J Alzheimers Dis; 2018; 61(1):295-307. PubMed ID: 29154268
[TBL] [Abstract][Full Text] [Related]
14. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.
Cummings J; Mintzer J; Brodaty H; Sano M; Banerjee S; Devanand DP; Gauthier S; Howard R; Lanctôt K; Lyketsos CG; Peskind E; Porsteinsson AP; Reich E; Sampaio C; Steffens D; Wortmann M; Zhong K;
Int Psychogeriatr; 2015 Jan; 27(1):7-17. PubMed ID: 25311499
[TBL] [Abstract][Full Text] [Related]
15. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
[TBL] [Abstract][Full Text] [Related]
16. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
Monsell SE; Liu D; Weintraub S; Kukull WA
Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
[TBL] [Abstract][Full Text] [Related]
17. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.
Morris JC; Weintraub S; Chui HC; Cummings J; Decarli C; Ferris S; Foster NL; Galasko D; Graff-Radford N; Peskind ER; Beekly D; Ramos EM; Kukull WA
Alzheimer Dis Assoc Disord; 2006; 20(4):210-6. PubMed ID: 17132964
[TBL] [Abstract][Full Text] [Related]
18. Remediable behavioral symptomatology in Alzheimer's disease.
Reisberg B; Borenstein J; Franssen E; Shulman E; Steinberg G; Ferris SH
Hosp Community Psychiatry; 1986 Dec; 37(12):1199-201. PubMed ID: 3804220
[No Abstract] [Full Text] [Related]
19. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
[TBL] [Abstract][Full Text] [Related]
20. 24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone.
Ruthirakuhan M; Herrmann N; Andreazza AC; Verhoeff NPLG; Gallagher D; Black SE; Kiss A; Lanctôt KL
J Alzheimers Dis; 2019; 71(1):21-31. PubMed ID: 31322567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
